Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of high dose creatine and two
dosages of tamoxifen treatment in amyotrophic lateral sclerosis (ALS).
Phase:
Phase 2
Details
Lead Sponsor:
Nazem Atassi
Collaborators:
ALS Therapy Alliance State University of New York - Upstate Medical University